Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1955 1
1958 1
1960 1
1968 2
1976 1
1978 1
1979 2
1981 2
1982 4
1983 5
1984 7
1985 1
1987 7
1988 5
1989 6
1990 8
1991 6
1992 9
1993 11
1994 4
1995 6
1996 10
1997 15
1998 11
1999 5
2000 14
2001 12
2002 22
2003 15
2004 24
2005 29
2006 25
2007 36
2008 29
2009 36
2010 53
2011 69
2012 48
2013 60
2014 38
2015 59
2016 48
2017 27
2018 53
2019 64
2020 39
2021 37
2022 28
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

922 results
Results by year
Filters applied: . Clear all
Page 1
Hyperkalemia in chronic kidney disease.
Watanabe R. Watanabe R. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s31-s36. doi: 10.1590/1806-9282.66.S1.31. Rev Assoc Med Bras (1992). 2020. PMID: 31939533 Free article. Review.
Patiromer for the treatment of hyperkalemia.
Colbert GB, Patel D, Lerma EV. Colbert GB, et al. Expert Rev Clin Pharmacol. 2020 Jun;13(6):563-570. doi: 10.1080/17512433.2020.1774363. Epub 2020 Jun 8. Expert Rev Clin Pharmacol. 2020. PMID: 32511052 Review.
Recently newer oral potassium-binding agents have been approved for clinical use, as an alternative to the decades long use of sodium polystyrene sulfonate. This review will focus on the patiromer and its use in reducing hyperkalemia. AREAS COVERED: Pubmed was used to sear …
Recently newer oral potassium-binding agents have been approved for clinical use, as an alternative to the decades long use of sodium pol
Acid-Base Interactions of Polystyrene Sulfonic Acid in Amorphous Solid Dispersions Using a Combined UV/FTIR/XPS/ssNMR Study.
Song Y, Zemlyanov D, Chen X, Nie H, Su Z, Fang K, Yang X, Smith D, Byrn S, Lubach JW. Song Y, et al. Mol Pharm. 2016 Feb 1;13(2):483-92. doi: 10.1021/acs.molpharmaceut.5b00708. Epub 2015 Dec 30. Mol Pharm. 2016. PMID: 26716395
This study investigates the potential drug-excipient interactions of polystyrene sulfonic acid (PSSA) and two weakly basic anticancer drugs, lapatinib (LB) and gefitinib (GB), in amorphous solid dispersions. Based on the strong acidity of the sulfonic
This study investigates the potential drug-excipient interactions of polystyrene sulfonic acid (PSSA) and two weakly ba …
Cross-linked polystyrene sulfonic acid and polyethylene glycol as a low-fouling material.
Alghunaim A, Zhang Newby BM. Alghunaim A, et al. Colloids Surf B Biointerfaces. 2016 Apr 1;140:514-522. doi: 10.1016/j.colsurfb.2016.01.026. Epub 2016 Jan 18. Colloids Surf B Biointerfaces. 2016. PMID: 26812639 Free PMC article.
A negatively charged hydrophilic low fouling film was prepared by thermally cross-linking a blend consisting of polystyrene sulfonic acid (PSS) and polyethylene glycol (PEG). The film was found to be stable by dip-washing. The fouling resistance of this mater …
A negatively charged hydrophilic low fouling film was prepared by thermally cross-linking a blend consisting of polystyrene sulfon
[Kayexalate].
Gervais C, de Longraye J. Gervais C, et al. Soins. 1984 Dec;(443-444):I-II. Soins. 1984. PMID: 6570569 French. No abstract available.
Extracellular and intracellular intermittent magnetic-fluid hyperthermia treatment of SK-Hep1 hepatocellular carcinoma cells based on magnetic nanoparticles coated with polystyrene sulfonic acid.
Chen BW, Chiu GW, He YC, Huang CY, Huang HT, Sung SY, Hsieh CL, Chang WC, Hsu MS, Wei ZH, Yao DJ. Chen BW, et al. PLoS One. 2021 Feb 5;16(2):e0245286. doi: 10.1371/journal.pone.0245286. eCollection 2021. PLoS One. 2021. PMID: 33544751 Free PMC article.
In previous work, we developed biocompatible and superparamagnetic polystyrene-sulfonic-acid-coated magnetic nanoparticles (PSS-MNPs) as applications for magnetically labeled cell trapping, but without assessment of treatment effects on tumor diseases. ...
In previous work, we developed biocompatible and superparamagnetic polystyrene-sulfonic-acid-coated magnetic nanopartic …
Magnetic graphene - polystyrene sulfonic acid nano composite: A dispersive cation exchange sorbent for the enrichment of aminoalcohols and ethanolamines from environmental aqueous samples.
Chinthakindi S, Purohit A, Singh V, Tak V, Dubey DK, Pardasani D. Chinthakindi S, et al. J Chromatogr A. 2015 Dec 4;1423:54-62. doi: 10.1016/j.chroma.2015.10.087. Epub 2015 Nov 2. J Chromatogr A. 2015. PMID: 26554296
Present study aimed at graphene surface modification to achieve selective analyte binding in dispersive solid phase extraction. Magnetic graphene - polystyrene sulfonic acid (MG-PSS) cation exchange nano-composite was prepared by non-covalent wrapping method. …
Present study aimed at graphene surface modification to achieve selective analyte binding in dispersive solid phase extraction. Magnetic gra …
Kayexalate-Induced Colonic Pseudotumor.
Chatila AT, Bilal M, Merwat S. Chatila AT, et al. Clin Gastroenterol Hepatol. 2019 Jun;17(7):e73. doi: 10.1016/j.cgh.2018.03.032. Epub 2018 Mar 30. Clin Gastroenterol Hepatol. 2019. PMID: 29609060 No abstract available.
Liposome-based nanocapsules.
Ruysschaert T, Germain M, Gomes JF, Fournier D, Sukhorukov GB, Meier W, Winterhalter M. Ruysschaert T, et al. IEEE Trans Nanobioscience. 2004 Mar;3(1):49-55. doi: 10.1109/tnb.2004.824273. IEEE Trans Nanobioscience. 2004. PMID: 15382644
922 results